RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma.
Oncotarget
; 7(24): 36711-36718, 2016 Jun 14.
Article
in En
| MEDLINE
| ID: mdl-27167340
Full text:
1
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Phosphatidylinositol 3-Kinases
/
MAP Kinase Signaling System
/
Proto-Oncogene Proteins B-raf
/
RNA, Long Noncoding
/
Melanoma
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Oncotarget
Year:
2016
Type:
Article
Affiliation country:
Brazil